Lisata Therapeutics, Inc. Common Stock

LSTANASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
2.24 USD
↘ 1.28 (36.30%)AT CLOSE (11:59 AM EDT)
2.20
↘ 0.05 (2.01%)
POST MARKET (AS OF 04:33 PM EDT)
Post Market
AS OF 04:33 PM EDT
2.20
↘ 0.05 (2.01%)
🟢Market: OPEN

Lisata Therapeutics, Inc. Common Stock (LSTA) is currently trading at $3.77. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. LSTA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jul 20, 2026.

Open?$2.51
High?$2.56
Low?$1.95
Prev. Close?$3.53
Volume?558.4K
Avg. Volume?70.0K
VWAP?$2.19
Rel. Volume?7.97x
Bid / Ask
Bid?$1.86 × 100
Ask?$2.55 × 100
Spread?$0.69
Midpoint?$2.21
Valuation & Ratios
Market Cap?32.1M
Shares Out?9.1M
Float?7.2M
Float %?79.1%
P/E Ratio?N/A
P/B Ratio?2.94
EPS?-$1.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
21
Market Cap
32.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.lisata.com
Listed
1999-03-01
Address
110 ALLEN ROAD
BASKING RIDGE, NJ 07920
Phone: 908-229-2590
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
68
Piotroski F-Score?0/9Weak
Altman Z-Score?-54.12Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?1.46%Low
Short Interest?104.8K
Days to Cover?5.2
Free Float7.2M
Avg Daily Volume20.0K
Settlement Date2026-06-30
Financial Health
Current Ratio?4.23Strong
Quick Ratio?4.23Strong
Cash Ratio?3.94Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
57
2.94CHEAP▾
P/S?
Peers
100
S&P
3
189.09HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.1CHEAP▾
EV/Sales?
Peers
100
S&P
3
112.27HIGH▾
Returns & Efficiency
ROE?
S&P
3
-149.7%WEAK▾
ROA?
S&P
3
-116.3%WEAK▾
Cash Flow & Enterprise
FCF?$-13630000
Enterprise Value?$19.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist